Climb Bio, Inc. (CLYM)
10.16
+1.29
(+14.54%)
USD |
NASDAQ |
Nov 06, 15:22
Climb Bio Net Income (TTM) : -57.62M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -57.62M |
| March 31, 2026 | -52.79M |
| December 31, 2025 | -59.85M |
| September 30, 2025 | -50.75M |
| June 30, 2025 | -46.76M |
| March 31, 2025 | -92.98M |
| December 31, 2024 | -73.90M |
| September 30, 2024 | -69.12M |
| June 30, 2024 | -64.20M |
| March 31, 2024 | -14.53M |
| December 31, 2023 | -35.12M |
| Date | Value |
|---|---|
| September 30, 2023 | -39.24M |
| June 30, 2023 | -44.95M |
| March 31, 2023 | -54.33M |
| December 31, 2022 | -45.24M |
| September 30, 2022 | -48.03M |
| June 30, 2022 | -47.96M |
| March 31, 2022 | -42.08M |
| December 31, 2021 | -47.48M |
| September 30, 2021 | -39.19M |
| June 30, 2021 | -31.21M |
| March 31, 2021 | -24.41M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Korsana Biosciences, Inc. | -6.707M |
| Cullinan Therapeutics, Inc. | -204.69M |
| Q32 Bio, Inc. | 32.25M |
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Oncolytics Biotech, Inc. | -30.07M |